GILD Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2024-03-28 | 2022 | Andrew D. Dickinson Chief Financial Officer | 1,018,419 | 0 | 3,992,603 | 1,885,572 | 31,121 | 8,402,698 |
| 2024-03-28 | 2022 | Deborah H. Telman Executive Vice President, Corporate Affairs and General Counsel | 380,769 | 1,200,000 | 1,999,890 | 536,548 | 205,763 | 4,822,949 |
| 2024-03-28 | 2023 | Deborah H. Telman Executive Vice President, Corporate Affairs and General Counsel | 936,865 | 0 | 1,895,703 | 1,288,980 | 337,168 | 5,271,228 |
| 2024-03-28 | 2021 | Merdad V. Parsey, M.D., Ph.D. Chief Medical Officer | 1,024,808 | 0 | 2,773,579 | 1,640,790 | 15,000 | 6,516,679 |
| 2024-03-28 | 2022 | Merdad V. Parsey, M.D., Ph.D. Chief Medical Officer | 1,072,800 | 0 | 4,350,004 | 1,986,552 | 15,362 | 9,037,214 |
| 2024-03-28 | 2023 | Merdad V. Parsey, M.D., Ph.D. Chief Medical Officer | 1,108,215 | 0 | 4,269,768 | 1,657,632 | 26,248 | 8,386,847 |
| 2024-03-28 | 2021 | Johanna Mercier Chief Commercial Officer | 1,050,428 | 0 | 2,620,663 | 1,557,231 | 311,790 | 6,552,597 |
| 2024-03-28 | 2022 | Johanna Mercier Chief Commercial Officer | 1,081,471 | 0 | 4,301,757 | 1,995,732 | 244,997 | 9,236,453 |
| 2024-03-28 | 2023 | Johanna Mercier Chief Commercial Officer | 1,114,035 | 0 | 4,190,733 | 1,805,440 | 176,580 | 8,586,754 |
| 2024-03-28 | 2021 | Andrew D. Dickinson Chief Financial Officer | 973,567 | 0 | 2,862,493 | 1,558,751 | 15,000 | 6,459,795 |
| 2024-03-28 | 2023 | Daniel P. O’Day Chairman and Chief Executive Officer | 1,740,962 | 0 | 11,865,090 | 4,036,200 | 1,215,472 | 22,607,690 |
| 2024-03-28 | 2022 | Daniel P. O’Day Chairman and Chief Executive Officer | 1,691,154 | 0 | 10,603,901 | 4,716,480 | 859,704 | 21,621,253 |
| 2024-03-28 | 2021 | Daniel P. O’Day Chairman and Chief Executive Officer | 1,650,000 | 0 | 9,764,060 | 3,446,190 | 994,212 | 19,229,466 |
| 2024-03-28 | 2023 | Andrew D. Dickinson Chief Financial Officer | 1,052,396 | 0 | 4,143,271 | 1,574,304 | 37,886 | 8,107,823 |
| 2023-03-23 | 2022 | Merdad V. Parsey, M.D., Ph.D. Chief Medical Officer | 1,072,800 | 0 | 4,350,004 | 1,986,552 | 15,362 | 9,037,214 |
| 2023-03-23 | 2020 | Johanna Mercier Chief Commercial Officer | 1,059,135 | 1,600,000 | 2,042,265 | 1,980,300 | 220,243 | 7,776,911 |
| 2023-03-23 | 2021 | Johanna Mercier Chief Commercial Officer | 1,050,428 | 0 | 2,620,663 | 1,557,231 | 311,790 | 6,552,597 |
| 2023-03-23 | 2022 | Johanna Mercier Chief Commercial Officer | 1,081,471 | 0 | 4,301,757 | 1,995,732 | 244,997 | 9,236,453 |
| 2023-03-23 | 2020 | Andrew D. Dickinson Chief Financial Officer | 986,538 | 0 | 2,260,949 | 1,704,300 | 15,000 | 5,841,755 |
| 2023-03-23 | 2021 | Andrew D. Dickinson Chief Financial Officer | 973,567 | 0 | 2,862,493 | 1,558,751 | 15,000 | 6,459,795 |
| 2023-03-23 | 2022 | Andrew D. Dickinson Chief Financial Officer | 1,018,419 | 0 | 3,992,603 | 1,885,572 | 31,121 | 8,402,698 |
| 2023-03-23 | 2020 | Daniel P. O’Day Chairman and Chief Executive Officer | 1,702,885 | 0 | 8,388,056 | 4,713,390 | 1,068,723 | 18,998,095 |
| 2023-03-23 | 2021 | Daniel P. O’Day Chairman and Chief Executive Officer | 1,650,000 | 0 | 9,764,060 | 3,446,190 | 994,212 | 19,229,466 |
| 2023-03-23 | 2022 | Daniel P. O’Day Chairman and Chief Executive Officer | 1,691,154 | 0 | 10,603,901 | 4,716,480 | 859,704 | 21,621,253 |
| 2023-03-23 | 2022 | Deborah H. Telman Executive Vice President, Corporate Affairs and General Counsel | 380,769 | 1,200,000 | 1,999,890 | 536,548 | 205,763 | 4,822,949 |
| 2023-03-23 | 2020 | Merdad V. Parsey, M.D., Ph.D. Chief Medical Officer | 1,038,462 | 1,000,000 | 2,332,860 | 1,794,000 | 15,000 | 7,180,355 |
| 2023-03-23 | 2021 | Merdad V. Parsey, M.D., Ph.D. Chief Medical Officer | 1,024,808 | 0 | 2,773,579 | 1,640,790 | 15,000 | 6,516,679 |
| 2022-03-24 | 2019 | Merdad V. Parsey, M.D., Ph.D. Chief Medical Officer | 119,231 | 1,000,000 | 1,000,314 | 0 | 0 | 3,119,553 |
| 2022-03-24 | 2020 | Merdad V. Parsey, M.D., Ph.D. Chief Medical Officer | 1,038,462 | 1,000,000 | 2,332,860 | 1,794,000 | 15,000 | 7,180,355 |
| 2022-03-24 | 2021 | Daniel P. O’Day Chairman and Chief Executive Officer | 1,650,000 | 0 | 9,764,060 | 3,446,190 | 994,212 | 19,229,466 |
| 2022-03-24 | 2021 | Merdad V. Parsey, M.D., Ph.D. Chief Medical Officer | 1,024,808 | 0 | 2,773,579 | 1,640,790 | 15,000 | 6,516,679 |
| 2022-03-24 | 2020 | Daniel P. O’Day Chairman and Chief Executive Officer | 1,702,885 | 0 | 8,388,056 | 4,713,390 | 1,068,723 | 18,998,095 |
| 2022-03-24 | 2019 | Daniel P. O’Day Chairman and Chief Executive Officer | 1,267,692 | 5,675,000 | 15,500,541 | 3,120,000 | 544,619 | 29,107,854 |
| 2022-03-24 | 2021 | Andrew D. Dickinson Chief Financial Officer | 973,567 | 0 | 2,862,493 | 1,558,751 | 15,000 | 6,459,795 |
| 2022-03-24 | 2020 | Andrew D. Dickinson Chief Financial Officer | 986,538 | 0 | 2,260,949 | 1,704,300 | 15,000 | 5,841,755 |
| 2022-03-24 | 2019 | Andrew D. Dickinson Chief Financial Officer | 802,308 | 1,000,000 | 1,708,267 | 1,086,800 | 12,000 | 5,609,471 |
| 2022-03-24 | 2021 | Johanna Mercier Chief Commercial Officer | 1,050,428 | 0 | 2,620,663 | 1,557,231 | 311,790 | 6,552,597 |
| 2022-03-24 | 2020 | Johanna Mercier Chief Commercial Officer | 1,059,135 | 1,600,000 | 2,042,265 | 1,980,300 | 220,243 | 7,776,911 |
| 2022-03-24 | 2019 | Johanna Mercier Chief Commercial Officer | 461,538 | 1,250,000 | 3,751,166 | 650,000 | 186,585 | 8,049,386 |
| 2022-03-24 | 2019 | Brett A. Pletcher Executive Vice President, Corporate Affairs and General Counsel | 891,000 | 0 | 2,144,734 | 1,235,000 | 12,000 | 5,032,680 |
| 2022-03-24 | 2020 | Brett A. Pletcher Executive Vice President, Corporate Affairs and General Counsel | 986,538 | 0 | 2,212,188 | 1,704,300 | 15,000 | 5,668,051 |
| 2022-03-24 | 2021 | Brett A. Pletcher Executive Vice President, Corporate Affairs and General Counsel | 973,567 | 0 | 2,320,424 | 1,443,288 | 52,746 | 5,590,031 |
| 2021-03-30 | 2020 | Brett A. Pletcher Executive Vice President, Corporate Affairs and General Counsel | 986,538 | 0 | 2,212,188 | 1,704,300 | 15,000 | 5,668,051 |
| 2021-03-30 | 2020 | Daniel P. O’Day Chairman and Chief Executive Officer | 1,702,885 | 0 | 8,388,056 | 4,713,390 | 1,068,723 | 18,998,095 |
| 2021-03-30 | 2019 | Daniel P. O’Day Chairman and Chief Executive Officer | 1,267,692 | 5,675,000 | 15,500,541 | 3,120,000 | 544,619 | 29,107,854 |
| 2021-03-30 | 2020 | Andrew D. Dickinson Chief Financial Officer | 986,538 | 0 | 2,260,949 | 1,704,300 | 15,000 | 5,841,755 |
| 2021-03-30 | 2019 | Andrew D. Dickinson Chief Financial Officer | 802,308 | 1,000,000 | 1,708,267 | 1,086,800 | 12,000 | 5,609,471 |
| 2021-03-30 | 2020 | Johanna Mercier Chief Commercial Officer | 1,059,135 | 1,600,000 | 2,042,265 | 1,980,300 | 220,243 | 7,776,911 |
| 2021-03-30 | 2019 | Johanna Mercier Chief Commercial Officer | 461,538 | 1,250,000 | 3,751,166 | 650,000 | 186,585 | 8,049,386 |
| 2021-03-30 | 2020 | Merdad V. Parsey, M.D., Ph.D. Chief Medical Officer | 1,038,462 | 1,000,000 | 2,332,860 | 1,794,000 | 15,000 | 7,180,355 |
| 2021-03-30 | 2019 | Merdad V. Parsey, M.D., Ph.D. Chief Medical Officer | 119,231 | 1,000,000 | 1,000,314 | 0 | 0 | 3,119,553 |
| 2021-03-30 | 2019 | Brett A. Pletcher Executive Vice President, Corporate Affairs and General Counsel | 891,000 | 0 | 2,144,734 | 1,235,000 | 12,000 | 5,032,680 |
| 2020-03-24 | 2019 | Johanna Mercier | 461,538 | 1,250,000 | 3,751,166 | 650,000 | 186,585 | 8,049,386 |
| 2020-03-24 | 2019 | Laura J. Hamill Former Executive Vice | 520,211 | 0 | 2,188,001 | 0 | 4,026,797 | 7,672,442 |
| 2020-03-24 | 2018 | Laura J. Hamill Former Executive Vice | 292,308 | 1,500,000 | 6,500,604 | 431,778 | 113,133 | 10,337,826 |
| 2020-03-24 | 2019 | John G. McHutchison, M.D. Former Chief Scientific Officer, Head of Research and Development | 640,096 | 0 | 2,683,888 | 0 | 1,112,000 | 5,435,962 |
| 2020-03-24 | 2018 | John G. McHutchison, M.D. Former Chief Scientific Officer, Head of Research and Development | 940,038 | 0 | 2,528,070 | 1,296,750 | 10,000 | 7,274,972 |
| 2020-03-24 | 2018 | Robin L. Washington Former Executive Vice President, Chief | 1,011,750 | 0 | 1,945,494 | 1,375,421 | 10,000 | 6,342,671 |
| 2020-03-24 | 2019 | Robin L. Washington Former Executive Vice President, Chief | 1,064,615 | 0 | 2,893,782 | 1,370,630 | 12,000 | 6,341,005 |
| 2020-03-24 | 2017 | Gregg H. Alton Former Interim Chief Executive Officer and Chief | 956,308 | 0 | 1,518,203 | 1,132,000 | 10,000 | 5,216,426 |
| 2020-03-24 | 2018 | Gregg H. Alton Former Interim Chief Executive Officer and Chief | 1,005,381 | 0 | 1,431,174 | 1,210,230 | 10,000 | 4,906,863 |
| 2020-03-24 | 2019 | Gregg H. Alton Former Interim Chief Executive Officer and Chief | 952,627 | 0 | 4,244,989 | 1,304,625 | 12,000 | 7,843,788 |
| 2020-03-24 | 2019 | Brett A. Pletcher | 891,000 | 0 | 2,144,734 | 1,235,000 | 12,000 | 5,032,680 |
| 2020-03-24 | 2019 | Merdad V. Parsey, M.D., | 119,231 | 1,000,000 | 1,000,314 | 0 | 0 | 3,119,553 |
| 2020-03-24 | 2017 | Robin L. Washington Former Executive Vice President, Chief | 953,231 | 0 | 1,613,500 | 1,152,600 | 10,000 | 5,529,346 |
| 2020-03-24 | 2019 | Daniel P. O’Day | 1,267,692 | 5,675,000 | 15,500,541 | 3,120,000 | 544,619 | 29,107,854 |
| 2020-03-24 | 2019 | Andrew D. Dickinson | 802,308 | 1,000,000 | 1,708,267 | 1,086,800 | 12,000 | 5,609,471 |
| 2019-03-25 | 2016 | John F. Milligan President and Chief Executive Officer | 1,465,385 | 0 | 4,349,750 | 2,610,000 | 10,000 | 13,935,212 |
| 2019-03-25 | 2018 | John G. McHutchison Chief Scientific Officer, Head of Research and Development | 940,038 | 0 | 2,528,070 | 1,296,750 | 10,000 | 7,274,972 |
| 2019-03-25 | 2018 | Laura J. Hamill Executive Vice President Worldwide Commercial Operations | 292,308 | 1,500,000 | 6,500,604 | 431,778 | 113,133 | 10,337,826 |
| 2019-03-25 | 2016 | Gregg H. Alton Chief Patient Officer | 925,385 | 0 | 1,695,597 | 944,648 | 10,000 | 5,325,570 |
| 2019-03-25 | 2017 | Gregg H. Alton Chief Patient Officer | 956,308 | 0 | 1,518,203 | 1,132,000 | 10,000 | 5,216,426 |
| 2019-03-25 | 2018 | Gregg H. Alton Chief Patient Officer | 1,005,381 | 0 | 1,431,174 | 1,210,230 | 10,000 | 4,906,863 |
| 2019-03-25 | 2016 | Robin L. Washington Executive Vice President and Chief Financial Officer | 900,385 | 0 | 1,619,221 | 938,485 | 10,000 | 5,068,062 |
| 2019-03-25 | 2017 | Robin L. Washington Executive Vice President and Chief Financial Officer | 953,231 | 0 | 1,613,500 | 1,152,600 | 10,000 | 5,529,346 |
| 2019-03-25 | 2018 | Robin L. Washington Executive Vice President and Chief Financial Officer | 1,011,750 | 0 | 1,945,494 | 1,375,421 | 10,000 | 6,342,671 |
| 2019-03-25 | 2017 | John F. Milligan President and Chief Executive Officer | 1,539,462 | 0 | 4,894,499 | 3,244,500 | 10,000 | 15,438,459 |
| 2019-03-25 | 2018 | John F. Milligan President and Chief Executive Officer | 1,581,623 | 0 | 9,865,666 | 3,341,100 | 42,056 | 25,961,831 |
| 2018-03-26 | 2015 | John C. Martin Executive Chairman | 1,727,423 | 0 | 7,232,654 | 4,038,525 | 7,500 | 18,755,952 |
| 2018-03-26 | 2015 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 994,231 | 0 | 2,576,436 | 1,275,000 | 7,500 | 6,953,071 |
| 2018-03-26 | 2017 | John F. Milligan President and Chief Executive Officer | 1,539,462 | 0 | 4,894,499 | 3,244,500 | 10,000 | 15,438,459 |
| 2018-03-26 | 2016 | John F. Milligan President and Chief Executive Officer | 1,465,385 | 0 | 4,349,750 | 2,610,000 | 10,000 | 13,935,212 |
| 2018-03-26 | 2015 | John F. Milligan President and Chief Executive Officer | 1,186,154 | 0 | 2,903,133 | 1,800,000 | 7,500 | 8,276,701 |
| 2018-03-26 | 2017 | John C. Martin Executive Chairman | 1,253,208 | 0 | 2,423,941 | 1,624,000 | 10,000 | 7,311,180 |
| 2018-03-26 | 2016 | John C. Martin Executive Chairman | 1,737,000 | 0 | 3,680,389 | 2,014,920 | 10,000 | 10,442,372 |
| 2018-03-26 | 2016 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 1,044,231 | 0 | 1,935,730 | 1,179,544 | 10,000 | 6,169,469 |
| 2018-03-26 | 2017 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 1,080,692 | 0 | 1,761,484 | 1,443,050 | 10,000 | 6,145,310 |
| 2018-03-26 | 2016 | Kevin Young Chief Operating Officer | 787,645 | 0 | 1,911,323 | 954,293 | 75,574 | 5,639,674 |
| 2018-03-26 | 2017 | Kevin Young Chief Operating Officer | 1,115,769 | 0 | 1,366,772 | 1,522,969 | 166,225 | 6,221,742 |
| 2018-03-26 | 2015 | Robin L. Washington Executive Vice President and Chief Financial Officer | 860,384 | 0 | 2,004,702 | 1,084,494 | 7,500 | 5,557,233 |
| 2018-03-26 | 2016 | Robin L. Washington Executive Vice President and Chief Financial Officer | 900,385 | 0 | 1,619,221 | 938,485 | 10,000 | 5,068,062 |
| 2018-03-26 | 2017 | Robin L. Washington Executive Vice President and Chief Financial Officer | 953,231 | 0 | 1,613,500 | 1,152,600 | 10,000 | 5,529,346 |
| 2017-03-27 | 2015 | John F. Milligan President and Chief Executive Officer as of March 10, 2016 | 1,186,154 | 0 | 2,903,133 | 1,800,000 | 7,500 | 8,276,701 |
| 2017-03-27 | 2016 | John C. Martin Executive Chairman (Chairman and Chief Executive Officer until March 9, 2016) | 1,737,000 | 0 | 3,680,389 | 2,014,920 | 10,000 | 10,442,372 |
| 2017-03-27 | 2014 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 920,647 | 0 | 2,905,986 | 1,111,500 | 8,820 | 6,794,187 |
| 2017-03-27 | 2016 | Kevin Young | 787,645 | 0 | 1,911,323 | 954,293 | 75,574 | 5,639,674 |
| 2017-03-27 | 2016 | Gregg H. Alton Executive Vice President, Corporate and Medical Affairs | 925,385 | 0 | 1,695,597 | 944,648 | 10,000 | 5,325,570 |
| 2017-03-27 | 2015 | Gregg H. Alton Executive Vice President, Corporate and Medical Affairs | 884,231 | 0 | 2,159,154 | 1,134,750 | 7,500 | 5,935,781 |
| 2017-03-27 | 2014 | Gregg H. Alton Executive Vice President, Corporate and Medical Affairs | 814,300 | 0 | 2,474,166 | 982,800 | 8,702 | 5,977,304 |
| 2017-03-27 | 2015 | John C. Martin Executive Chairman (Chairman and Chief Executive Officer until March 9, 2016) | 1,727,423 | 0 | 7,232,654 | 4,038,525 | 7,500 | 18,755,952 |
| 2017-03-27 | 2014 | John C. Martin Executive Chairman (Chairman and Chief Executive Officer until March 9, 2016) | 1,605,017 | 0 | 8,386,205 | 3,717,365 | 7,500 | 18,957,994 |
| 2017-03-27 | 2016 | Robin L. Washington Executive Vice President and Chief Financial Officer | 900,385 | 0 | 1,619,221 | 938,485 | 10,000 | 5,068,062 |
| 2017-03-27 | 2015 | Robin L. Washington Executive Vice President and Chief Financial Officer | 860,384 | 0 | 2,004,702 | 1,084,494 | 7,500 | 5,557,233 |
| 2017-03-27 | 2014 | Robin L. Washington Executive Vice President and Chief Financial Officer | 797,601 | 0 | 2,504,439 | 965,250 | 8,820 | 6,223,491 |
| 2017-03-27 | 2016 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 1,044,231 | 0 | 1,935,730 | 1,179,544 | 10,000 | 6,169,469 |
| 2017-03-27 | 2015 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 994,231 | 0 | 2,576,436 | 1,275,000 | 7,500 | 6,953,071 |
| 2017-03-27 | 2016 | John F. Milligan President and Chief Executive Officer as of March 10, 2016 | 1,465,385 | 0 | 4,349,750 | 2,610,000 | 10,000 | 13,935,212 |
| 2017-03-27 | 2014 | John F. Milligan President and Chief Executive Officer as of March 10, 2016 | 1,046,898 | 0 | 3,441,544 | 1,579,500 | 96,197 | 8,261,095 |
| 2016-03-28 | 2014 | Norbert W. Bischofberger Executive Vice President, Research and Development | 920,647 | 0 | 2,905,986 | 1,111,500 | 8,820 | 6,794,187 |
| 2016-03-28 | 2013 | Norbert W. Bischofberger Executive Vice President, Research and Development | 884,175 | 0 | 1,740,781 | 1,068,000 | 95,378 | 5,588,388 |
| 2016-03-28 | 2015 | Gregg H. Alton Executive Vice President, Corporate and Medical Affairs | 884,231 | 0 | 2,159,154 | 1,134,750 | 7,500 | 5,935,781 |
| 2016-03-28 | 2014 | Gregg H. Alton Executive Vice President, Corporate and Medical Affairs | 814,300 | 0 | 2,474,166 | 982,800 | 8,702 | 5,977,304 |
| 2016-03-28 | 2013 | John F. Milligan President and Chief Operating Officer | 1,010,010 | 0 | 2,026,247 | 1,522,500 | 7,500 | 6,566,287 |
| 2016-03-28 | 2015 | John C. Martin Chairman and Chief Executive Officer | 1,727,423 | 0 | 7,232,654 | 4,038,525 | 7,500 | 18,755,952 |
| 2016-03-28 | 2014 | John C. Martin Chairman and Chief Executive Officer | 1,605,017 | 0 | 8,386,205 | 3,717,365 | 7,500 | 18,957,994 |
| 2016-03-28 | 2013 | John C. Martin Chairman and Chief Executive Officer | 1,568,765 | 0 | 5,081,801 | 3,543,750 | 7,500 | 15,451,862 |
| 2016-03-28 | 2015 | Robin L. Washington Executive Vice President and Chief Financial Officer | 860,384 | 0 | 2,004,702 | 1,084,494 | 7,500 | 5,557,233 |
| 2016-03-28 | 2015 | Norbert W. Bischofberger Executive Vice President, Research and Development | 994,231 | 0 | 2,576,436 | 1,275,000 | 7,500 | 6,953,071 |
| 2016-03-28 | 2014 | Robin L. Washington Executive Vice President and Chief Financial Officer | 797,601 | 0 | 2,504,439 | 965,250 | 8,820 | 6,223,491 |
| 2016-03-28 | 2013 | Robin L. Washington Executive Vice President and Chief Financial Officer | 746,219 | 0 | 1,203,270 | 787,500 | 8,490 | 3,941,728 |
| 2016-03-28 | 2015 | John F. Milligan President and Chief Operating Officer | 1,186,154 | 0 | 2,903,133 | 1,800,000 | 7,500 | 8,276,701 |
| 2016-03-28 | 2014 | John F. Milligan President and Chief Operating Officer | 1,046,898 | 0 | 3,441,544 | 1,579,500 | 96,197 | 8,261,095 |
| 2015-03-27 | 2012 | John F. Milligan President and Chief Operating Officer | 950,864 | 0 | 2,166,978 | 1,420,563 | 7,500 | 7,028,704 |
| 2015-03-27 | 2013 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 884,175 | 0 | 1,740,781 | 1,068,000 | 95,378 | 5,588,388 |
| 2015-03-27 | 2014 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 920,647 | 0 | 2,905,986 | 1,111,500 | 8,820 | 6,794,187 |
| 2015-03-27 | 2014 | John F. Milligan President and Chief Operating Officer | 1,046,898 | 0 | 3,441,544 | 1,579,500 | 96,197 | 8,261,096 |
| 2015-03-27 | 2012 | Robin L. Washington Executive Vice President and Chief Financial Officer | 693,356 | 0 | 1,268,494 | 728,875 | 7,500 | 4,175,593 |
| 2015-03-27 | 2013 | Robin L. Washington Executive Vice President and Chief Financial Officer | 746,219 | 0 | 1,203,270 | 787,500 | 8,490 | 3,941,728 |
| 2015-03-27 | 2014 | Robin L. Washington Executive Vice President and Chief Financial Officer | 797,601 | 0 | 2,504,439 | 965,250 | 8,820 | 6,223,492 |
| 2015-03-27 | 2012 | John C. Martin Chairman and Chief Executive Officer | 1,494,214 | 0 | 4,947,127 | 3,375,000 | 7,500 | 15,257,272 |
| 2015-03-27 | 2013 | John F. Milligan President and Chief Operating Officer | 1,010,010 | 0 | 2,026,247 | 1,522,500 | 7,500 | 6,566,287 |
| 2015-03-27 | 2013 | John C. Martin Chairman and Chief Executive Officer | 1,568,765 | 0 | 5,081,801 | 3,543,750 | 7,500 | 15,451,862 |
| 2015-03-27 | 2014 | John C. Martin Chairman and Chief Executive Officer | 1,605,017 | 0 | 8,386,205 | 3,717,365 | 7,500 | 18,957,994 |
| 2015-03-27 | 2014 | Gregg H. Alton | 814,300 | 0 | 2,474,166 | 982,800 | 8,702 | 5,977,304 |
| 2015-03-27 | 2012 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 815,026 | 0 | 1,691,293 | 975,800 | 7,500 | 5,397,886 |
| 2014-03-24 | 2011 | John C. Martin Chairman and Chief Executive Officer | 1,423,354 | 0 | 5,535,569 | 2,788,500 | 5,000 | 15,615,645 |
| 2014-03-24 | 2012 | John C. Martin Chairman and Chief Executive Officer | 1,494,214 | 0 | 4,947,127 | 3,375,000 | 7,500 | 15,257,272 |
| 2014-03-24 | 2013 | John C. Martin Chairman and Chief Executive Officer | 1,568,765 | 0 | 5,081,801 | 3,543,750 | 7,500 | 15,451,862 |
| 2014-03-24 | 2011 | Kevin Young Former Executive Vice President, Commercial Operations | 711,260 | 0 | 1,614,541 | 743,243 | 5,000 | 4,696,657 |
| 2014-03-24 | 2012 | Kevin Young Former Executive Vice President, Commercial Operations | 756,274 | 0 | 1,353,044 | 904,400 | 7,500 | 4,564,247 |
| 2014-03-24 | 2013 | Kevin Young Former Executive Vice President, Commercial Operations | 810,424 | 0 | 2,148,828 | 978,000 | 7,500 | 5,394,714 |
| 2014-03-24 | 2011 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 756,261 | 0 | 1,614,541 | 794,010 | 5,000 | 4,792,425 |
| 2014-03-24 | 2012 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 815,026 | 0 | 1,691,293 | 975,800 | 7,500 | 5,397,886 |
| 2014-03-24 | 2013 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 884,175 | 0 | 1,740,781 | 1,068,000 | 95,378 | 5,588,388 |
| 2014-03-24 | 2011 | John F. Milligan President and Chief Operating Officer | 902,098 | 0 | 2,444,876 | 1,215,641 | 17,355 | 7,197,967 |
| 2014-03-24 | 2012 | John F. Milligan President and Chief Operating Officer | 950,864 | 0 | 2,166,978 | 1,420,563 | 7,500 | 7,028,704 |
| 2014-03-24 | 2013 | John F. Milligan President and Chief Operating Officer | 1,010,010 | 0 | 2,026,247 | 1,522,500 | 7,500 | 6,566,287 |
| 2014-03-24 | 2011 | Robin L. Washington Executive Vice President and Chief Financial Officer | 615,175 | 0 | 1,596,897 | 555,210 | 5,000 | 4,032,193 |
| 2014-03-24 | 2012 | Robin L. Washington Executive Vice President and Chief Financial Officer | 693,356 | 0 | 1,268,494 | 728,875 | 7,500 | 4,175,593 |
| 2014-03-24 | 2013 | Robin L. Washington Executive Vice President and Chief Financial Officer | 746,219 | 0 | 1,203,270 | 787,500 | 8,490 | 3,941,728 |
| 2013-03-19 | 2010 | John F. Milligan President and Chief Operating Officer | 865,008 | 0 | 2,658,250 | 1,013,006 | 20,135 | 6,679,219 |
| 2013-03-19 | 2012 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 815,026 | 0 | 1,691,293 | 975,800 | 7,500 | 5,397,886 |
| 2013-03-19 | 2011 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 756,261 | 0 | 1,614,541 | 794,010 | 5,000 | 4,792,425 |
| 2013-03-19 | 2012 | John C. Martin Chairman and Chief Executive Officer | 1,494,214 | 0 | 4,947,127 | 3,375,000 | 7,500 | 15,257,272 |
| 2013-03-19 | 2011 | John C. Martin Chairman and Chief Executive Officer | 1,423,354 | 0 | 5,535,569 | 2,788,500 | 5,000 | 15,615,645 |
| 2013-03-19 | 2010 | John C. Martin Chairman and Chief Executive Officer | 1,341,679 | 0 | 5,750,500 | 2,325,375 | 5,000 | 14,244,388 |
| 2013-03-19 | 2010 | Kevin Young Executive Vice President, Commercial Operations | 664,175 | 0 | 1,573,250 | 630,219 | 5,000 | 4,191,825 |
| 2013-03-19 | 2010 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 712,090 | 0 | 1,302,000 | 665,039 | 5,000 | 3,775,865 |
| 2013-03-19 | 2012 | Kevin Young Executive Vice President, Commercial Operations | 756,274 | 0 | 1,353,044 | 904,400 | 7,500 | 4,564,247 |
| 2013-03-19 | 2011 | Kevin Young Executive Vice President, Commercial Operations | 711,260 | 0 | 1,614,541 | 743,243 | 5,000 | 4,696,657 |
| 2013-03-19 | 2012 | Robin L. Washington Senior Vice President and Chief Financial Officer | 693,356 | 0 | 1,268,494 | 728,875 | 7,500 | 4,175,593 |
| 2013-03-19 | 2011 | Robin L. Washington Senior Vice President and Chief Financial Officer | 615,175 | 0 | 1,596,897 | 555,210 | 5,000 | 4,032,193 |
| 2013-03-19 | 2010 | Robin L. Washington Senior Vice President and Chief Financial Officer | 559,339 | 0 | 1,560,750 | 453,113 | 5,000 | 3,306,026 |
| 2013-03-19 | 2012 | John F. Milligan President and Chief Operating Officer | 950,864 | 0 | 2,166,978 | 1,420,563 | 7,500 | 7,028,704 |
| 2013-03-19 | 2011 | John F. Milligan President and Chief Operating Officer | 902,098 | 0 | 2,444,876 | 1,215,641 | 17,355 | 7,197,967 |
| 2012-03-20 | 2009 | Robin L. Washington Senior Vice President and Chief Financial Officer | 527,505 | 0 | 1,237,871 | 394,640 | 5,000 | 3,522,459 |
| 2012-03-20 | 2011 | John F. Milligan President and Chief Operating Officer | 902,098 | 0 | 2,444,876 | 1,215,641 | 17,355 | 7,197,967 |
| 2012-03-20 | 2010 | John F. Milligan President and Chief Operating Officer | 865,008 | 0 | 2,658,250 | 1,013,006 | 20,135 | 6,679,219 |
| 2012-03-20 | 2009 | John F. Milligan President and Chief Operating Officer | 805,008 | 0 | 2,908,997 | 850,500 | 21,130 | 6,942,759 |
| 2012-03-20 | 2009 | John C. Martin Chairman and Chief Executive Officer | 1,242,095 | 0 | 6,189,356 | 2,187,500 | 5,300 | 14,675,231 |
| 2012-03-20 | 2011 | Robin L. Washington Senior Vice President and Chief Financial Officer | 615,175 | 0 | 1,596,897 | 555,210 | 5,000 | 4,032,193 |
| 2012-03-20 | 2010 | Robin L. Washington Senior Vice President and Chief Financial Officer | 559,339 | 0 | 1,560,750 | 453,113 | 5,000 | 3,306,026 |
| 2012-03-20 | 2011 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 756,261 | 0 | 1,614,541 | 794,010 | 5,000 | 4,792,425 |
| 2012-03-20 | 2010 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 712,090 | 0 | 1,302,000 | 665,039 | 5,000 | 3,775,865 |
| 2012-03-20 | 2009 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 677,923 | 0 | 1,633,990 | 550,800 | 5,400 | 4,201,572 |
| 2012-03-20 | 2011 | Kevin Young Executive Vice President, Commercial Operations | 711,260 | 0 | 1,614,541 | 743,243 | 5,000 | 4,696,657 |
| 2012-03-20 | 2010 | Kevin Young Executive Vice President, Commercial Operations | 664,175 | 0 | 1,573,250 | 630,219 | 5,000 | 4,191,825 |
| 2012-03-20 | 2009 | Kevin Young Executive Vice President, Commercial Operations | 596,672 | 0 | 1,906,322 | 504,450 | 5,000 | 4,568,146 |
| 2012-03-20 | 2010 | John C. Martin Chairman and Chief Executive Officer | 1,341,679 | 0 | 5,750,500 | 2,325,375 | 5,000 | 14,244,388 |
| 2012-03-20 | 2011 | John C. Martin Chairman and Chief Executive Officer | 1,423,354 | 0 | 5,535,569 | 2,788,500 | 5,000 | 15,615,645 |
| 2011-03-22 | 2010 | John C. Martin Chairman and Chief Executive Officer | 1,341,679 | 0 | 5,750,500 | 2,325,375 | 5,000 | 14,244,388 |
| 2011-03-22 | 2008 | Gregg H. Alton Executive Vice President, Corporate and Medical Affairs | 493,338 | 0 | 378,155 | 298,125 | 5,300 | 3,067,938 |
| 2011-03-22 | 2009 | Gregg H. Alton Executive Vice President, Corporate and Medical Affairs | 557,505 | 0 | 1,237,871 | 467,351 | 5,400 | 3,883,377 |
| 2011-03-22 | 2010 | Gregg H. Alton Executive Vice President, Corporate and Medical Affairs | 635,839 | 0 | 1,519,000 | 602,000 | 5,000 | 4,035,531 |
| 2011-03-22 | 2009 | John C. Martin Chairman and Chief Executive Officer | 1,242,095 | 0 | 6,189,356 | 2,187,500 | 5,300 | 14,675,231 |
| 2011-03-22 | 2008 | John C. Martin Chairman and Chief Executive Officer | 1,146,261 | 0 | 2,789,741 | 1,651,650 | 107,131 | 12,553,943 |
| 2011-03-22 | 2010 | Robin L. Washington Senior Vice President and Chief Financial Officer | 559,339 | 0 | 1,560,750 | 453,113 | 5,000 | 3,306,026 |
| 2011-03-22 | 2009 | Robin L. Washington Senior Vice President and Chief Financial Officer | 527,505 | 0 | 1,237,871 | 394,640 | 5,000 | 3,522,459 |
| 2011-03-22 | 2008 | Robin L. Washington Senior Vice President and Chief Financial Officer | 329,811 | 125,000 | 812,100 | 192,602 | 5,000 | 3,334,683 |
| 2011-03-22 | 2010 | John F. Milligan President and Chief Operating Officer | 865,008 | 0 | 2,658,250 | 1,013,006 | 20,135 | 6,679,219 |
| 2011-03-22 | 2009 | John F. Milligan President and Chief Operating Officer | 805,008 | 0 | 2,908,997 | 850,500 | 21,130 | 6,942,759 |
| 2011-03-22 | 2008 | John F. Milligan President and Chief Operating Officer | 727,988 | 0 | 1,018,980 | 693,589 | 21,008 | 5,703,873 |
| 2011-03-22 | 2010 | Kevin Young Executive Vice President, Commercial Operations | 664,175 | 0 | 1,573,250 | 630,219 | 5,000 | 4,191,825 |
| 2011-03-22 | 2009 | Kevin Young Executive Vice President, Commercial Operations | 596,672 | 0 | 1,906,322 | 504,450 | 5,000 | 4,568,146 |
| 2011-03-22 | 2008 | Kevin Young Executive Vice President, Commercial Operations | 557,505 | 0 | 877,455 | 440,160 | 13,318 | 4,070,898 |
| 2010-03-22 | 2008 | John C. Martin Chairman and Chief Executive Officer | 1,146,261 | 0 | 2,789,741 | 1,651,650 | 107,131 | 12,553,943 |
| 2010-03-22 | 2007 | John C. Martin Chairman and Chief Executive Officer | 1,045,833 | 0 | 2,716,788 | 1,617,000 | 3,800 | 12,721,931 |
| 2010-03-22 | 2009 | Robin L. Washington Senior Vice President and Chief Financial Officer | 527,505 | 0 | 1,237,871 | 398,640 | 5,000 | 3,526,459 |
| 2010-03-22 | 2008 | Robin L. Washington Senior Vice President and Chief Financial Officer | 329,811 | 125,000 | 812,100 | 192,602 | 5,000 | 3,334,683 |
| 2010-03-22 | 2009 | John F. Milligan President and Chief Operating Officer | 805,008 | 0 | 2,908,997 | 850,500 | 21,130 | 6,942,759 |
| 2010-03-22 | 2008 | John F. Milligan President and Chief Operating Officer | 727,988 | 0 | 1,018,980 | 693,589 | 21,008 | 5,703,873 |
| 2010-03-22 | 2007 | John F. Milligan President and Chief Operating Officer | 626,340 | 0 | 1,086,715 | 541,800 | 20,402 | 6,833,538 |
| 2010-03-22 | 2009 | Kevin Young Executive Vice President, Commercial Operations | 596,672 | 0 | 1,906,322 | 504,450 | 5,000 | 4,568,146 |
| 2010-03-22 | 2008 | Kevin Young Executive Vice President, Commercial Operations | 557,505 | 0 | 877,455 | 440,160 | 13,318 | 4,070,898 |
| 2010-03-22 | 2007 | Kevin Young Executive Vice President, Commercial Operations | 527,500 | 0 | 1,009,093 | 445,200 | 26,755 | 6,322,212 |
| 2010-03-22 | 2009 | Norbert W. Bischofberger | 677,923 | 0 | 1,633,990 | 550,800 | 5,400 | 4,201,572 |
| 2010-03-22 | 2009 | Louis G. Lange | 325,276 | 0 | 2,221,595 | 130,534 | 7,447,610 | 11,873,889 |
| 2010-03-22 | 2009 | John C. Martin Chairman and Chief Executive Officer | 1,242,095 | 0 | 6,189,356 | 2,187,500 | 5,300 | 14,675,231 |
| 2009-03-12 | 2007 | John F. Milligan President and Chief Operating Officer | 626,340 | 0 | 651,440 | 541,800 | 20,402 | 4,902,386 |
| 2009-03-12 | 2008 | John C. Martin Chairman and Chief Executive Officer | 1,146,261 | 0 | 1,799,057 | 1,651,650 | 107,131 | 10,998,006 |
| 2009-03-12 | 2008 | Caroline Dorsa Former Senior Vice President Chief Financial Officer | 24,680 | 0 | 0 | 0 | 0 | 24,680 |
| 2009-03-12 | 2007 | Caroline Dorsa Former Senior Vice President Chief Financial Officer | 79,807 | 250,000 | 0 | 0 | 56,927 | 402,482 |
| 2009-03-12 | 2008 | Gregg H. Alton Senior Vice President and General Counsel | 493,338 | 0 | 270,580 | 298,125 | 5,300 | 2,682,789 |
| 2009-03-12 | 2007 | Gregg H. Alton Senior Vice President and General Counsel | 416,667 | 0 | 265,664 | 235,200 | 3,800 | 2,517,239 |
| 2009-03-12 | 2006 | Kevin Young Executive Vice President, Commercial Operations | 495,833 | 133,333 | 0 | 431,250 | 18,975 | 3,355,196 |
| 2009-03-12 | 2007 | Kevin Young Executive Vice President, Commercial Operations | 527,500 | 0 | 604,909 | 445,200 | 26,755 | 4,194,688 |
| 2009-03-12 | 2008 | Kevin Young Executive Vice President, Commercial Operations | 557,505 | 0 | 620,967 | 440,160 | 13,318 | 4,364,971 |
| 2009-03-12 | 2006 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 607,500 | 0 | 0 | 526,125 | 3,756 | 4,242,611 |
| 2009-03-12 | 2007 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 637,958 | 0 | 604,909 | 523,609 | 3,800 | 4,643,420 |
| 2009-03-12 | 2008 | Norbert W. Bischofberger Executive Vice President, Research and Development and Chief Scientific Officer | 653,798 | 0 | 587,263 | 495,180 | 5,350 | 4,390,994 |
| 2009-03-12 | 2006 | John F. Milligan President and Chief Operating Officer | 545,833 | 0 | 0 | 474,375 | 9,677 | 4,214,450 |
| 2009-03-12 | 2007 | John C. Martin Chairman and Chief Executive Officer | 1,045,833 | 0 | 1,628,601 | 1,617,000 | 3,800 | 10,801,539 |
| 2009-03-12 | 2008 | John F. Milligan President and Chief Operating Officer | 727,988 | 0 | 690,772 | 693,589 | 21,008 | 5,187,437 |
| 2009-03-12 | 2008 | Robin L. Washington | 329,811 | 125,000 | 270,700 | 192,602 | 5,000 | 1,166,870 |
| 2009-03-12 | 2006 | John C. Martin Chairman and Chief Executive Officer | 997,917 | 0 | 0 | 1,450,000 | 3,670 | 9,608,496 |
| 2008-03-20 | 2007 | John F. Milligan, Chief Operating Officer and | 626,340 | 0 | 651,440 | 541,800 | 20,402 | 4,902,386 |
| 2008-03-20 | 2006 | John C. Martin, President and Chief Executive Officer | 997,917 | 0 | 0 | 1,450,000 | 3,670 | 9,608,496 |
| 2008-03-20 | 2007 | Gregg H. Alton, | 416,667 | 0 | 265,664 | 235,200 | 3,800 | 2,517,239 |
| 2008-03-20 | 2006 | Kevin Young, Executive Vice President, | 495,833 | 133,333 | 0 | 431,250 | 18,975 | 3,355,196 |
| 2008-03-20 | 2007 | Kevin Young, Executive Vice President, | 527,500 | 0 | 604,909 | 445,200 | 16,253 | 4,184,186 |
| 2008-03-20 | 2006 | Norbert W. Bischofberger, Executive Vice President, Research and Development and Chief Scientific Officer | 607,500 | 0 | 0 | 526,125 | 3,756 | 4,242,611 |
| 2008-03-20 | 2007 | Norbert W. Bischofberger, Executive Vice President, Research and Development and Chief Scientific Officer | 637,958 | 0 | 604,909 | 523,609 | 3,800 | 4,643,420 |
| 2008-03-20 | 2007 | John C. Martin, President and Chief Executive Officer | 1,045,833 | 0 | 1,628,601 | 1,617,000 | 3,800 | 10,801,539 |
| 2008-03-20 | 2006 | John F. Milligan, Chief Operating Officer and | 545,833 | 0 | 0 | 474,375 | 9,677 | 4,214,450 |
| 2008-03-20 | 2007 | Caroline Dorsa, | 79,807 | 250,000 | 0 | 0 | 56,927 | 402,482 |
| 2007-03-23 | 2006 | John C. Martin, President and Chief Executive Officer | 997,917 | 0 | 0 | 1,450,000 | 3,670 | 9,608,496 |
| 2007-03-23 | 2006 | John F. Milligan, Executive Vice President, Chief Operating Officer and Chief Financial Officer | 545,833 | 0 | 0 | 474,375 | 9,677 | 4,214,450 |
| 2007-03-23 | 2006 | John T. Toole, Senior Vice President, Clinical Research | 368,333 | 0 | 0 | 205,350 | 3,435 | 2,413,728 |
| 2007-03-23 | 2006 | Kevin Young, | 495,833 | 133,333 | 0 | 431,250 | 18,975 | 3,355,196 |
| 2007-03-23 | 2006 | Norbert W. Bischofberger, Executive Vice President, Research and Development and Chief Scientific Officer | 607,500 | 0 | 0 | 526,125 | 3,756 | 4,242,611 |
| 2006-03-23 | 2004 | William A. Lee Senior Vice President, Research | 0 | 0 | 0 | 0 | 3,587 | 533,212 |
| 2006-03-23 | 2003 | William A. Lee Senior Vice President, Research | 0 | 0 | 0 | 0 | 3,520 | 475,326 |
| 2006-03-23 | 2005 | William A. Lee Senior Vice President, Research | 0 | 0 | 0 | 0 | 4,414 | 569,775 |
| 2006-03-23 | 2003 | Kevin Young Executive Vice President, Commercial | 0 | 0 | 0 | 0 | 0 | 0 |
| 2006-03-23 | 2004 | Kevin Young Executive Vice President, Commercial | 0 | 0 | 0 | 0 | 17,968 | 387,726 |
| 2006-03-23 | 2005 | Kevin Young Executive Vice President, Commercial | 0 | 0 | 0 | 0 | 39,315 | 1,003,928 |
| 2006-03-23 | 2003 | John F. Milligan Executive Vice President and Chief | 0 | 0 | 0 | 0 | 9,153 | 590,178 |
| 2006-03-23 | 2004 | John F. Milligan Executive Vice President and Chief | 0 | 0 | 0 | 0 | 9,292 | 839,434 |
| 2006-03-23 | 2005 | John F. Milligan Executive Vice President and Chief | 0 | 0 | 0 | 0 | 9,597 | 931,405 |
| 2006-03-23 | 2003 | Norbert W. Bischofberger Executive Vice President, Research and | 0 | 0 | 0 | 0 | 3,526 | 911,879 |
| 2006-03-23 | 2004 | Norbert W. Bischofberger Executive Vice President, Research and | 0 | 0 | 0 | 0 | 3,783 | 1,005,250 |
| 2006-03-23 | 2005 | Norbert W. Bischofberger Executive Vice President, Research and | 0 | 0 | 0 | 0 | 4,210 | 1,074,902 |
| 2006-03-23 | 2003 | John C. Martin President and Chief Executive Officer | 0 | 0 | 0 | 0 | 4,073 | 1,646,823 |
| 2006-03-23 | 2004 | John C. Martin President and Chief Executive Officer | 0 | 0 | 0 | 0 | 4,467 | 1,895,267 |
| 2006-03-23 | 2005 | John C. Martin President and Chief Executive Officer | 0 | 0 | 0 | 0 | 5,122 | 2,084,055 |
| 2005-03-25 | 2002 | John F. Milligan Executive Vice President and Chief Financial Officer | 272,433 | 163,548 | 0 | 0 | 2,500 | 438,481 |
| 2005-03-25 | 2002 | William A. Lee Senior Vice President, Research | 277,259 | 165,716 | 0 | 0 | 2,500 | 445,475 |
| 2005-03-25 | 2002 | John C. Martin President and Chief Executive Officer | 650,834 | 792,000 | 0 | 0 | 2,500 | 1,445,334 |
| 2005-03-25 | 2004 | Norbert W. Bischofberger Executive Vice President, Research and Development | 535,417 | 465,750 | 0 | 0 | 2,500 | 1,003,667 |
| 2005-03-25 | 2003 | Norbert W. Bischofberger Executive Vice President, Research and Development | 480,583 | 427,770 | 0 | 0 | 2,500 | 910,853 |
| 2005-03-25 | 2004 | John C. Martin President and Chief Executive Officer | 870,000 | 1,020,800 | 0 | 0 | 13,001 | 1,903,801 |
| 2005-03-25 | 2003 | William A. Lee Senior Vice President, Research | 295,906 | 173,400 | 0 | 0 | 2,500 | 471,806 |
| 2005-03-25 | 2004 | William A. Lee Senior Vice President, Research | 341,250 | 188,025 | 0 | 0 | 2,500 | 531,775 |
| 2005-03-25 | 2002 | John J. Toole Senior Vice President, Clinical Research | 263,289 | 89,214 | 0 | 0 | 2,500 | 355,003 |
| 2005-03-25 | 2003 | John J. Toole Senior Vice President, Clinical Research | 282,556 | 144,262 | 0 | 0 | 2,500 | 429,318 |
| 2005-03-25 | 2004 | John J. Toole Senior Vice President, Clinical Research | 317,683 | 177,600 | 0 | 0 | 2,500 | 497,783 |
| 2005-03-25 | 2002 | Michael K. Inouye Senior Vice President, Sales and Marketing | 307,798 | 176,700 | 0 | 0 | 12,500 | 496,998 |
| 2005-03-25 | 2003 | Michael K. Inouye Senior Vice President, Sales and Marketing | 327,050 | 181,716 | 0 | 0 | 12,500 | 521,266 |
| 2005-03-25 | 2004 | Michael K. Inouye Senior Vice President, Sales and Marketing | 348,217 | 187,250 | 0 | 0 | 10,000 | 545,467 |
| 2005-03-25 | 2003 | John C. Martin President and Chief Executive Officer | 751,667 | 887,680 | 0 | 0 | 10,190 | 1,649,537 |
| 2005-03-25 | 2003 | John F. Milligan Executive Vice President and Chief Financial Officer | 328,933 | 244,446 | 0 | 0 | 4,136 | 577,515 |
| 2005-03-25 | 2004 | John F. Milligan Executive Vice President and Chief Financial Officer | 441,667 | 388,125 | 0 | 0 | 2,500 | 832,292 |
| 2005-03-25 | 2002 | Norbert W. Bischofberger Executive Vice President, Research and Development | 427,250 | 382,320 | 0 | 0 | 2,500 | 812,070 |
| 2004-04-12 | 2003 | John C. Martin President and Chief Executive Officer | 754,167 | 887,680 | 0 | 0 | 0 | 1,641,847 |
| 2004-04-12 | 2002 | John C. Martin President and Chief Executive Officer | 653,334 | 792,000 | 0 | 0 | 0 | 1,445,334 |
| 2004-04-12 | 2001 | John C. Martin President and Chief Executive Officer | 548,340 | 616,000 | 0 | 0 | 0 | 1,164,340 |
| 2004-04-12 | 2003 | Norbert W. Bischofberger Executive Vice President, Research and Development | 483,083 | 427,770 | 0 | 0 | 0 | 910,853 |
| 2004-04-12 | 2002 | Norbert W. Bischofberger Executive Vice President, Research and Development | 429,750 | 382,320 | 0 | 0 | 0 | 812,070 |
| 2004-04-12 | 2001 | Norbert W. Bischofberger Executive Vice President, Research and Development | 375,417 | 315,000 | 0 | 0 | 0 | 690,417 |
| 2004-04-12 | 2003 | Mark L. Perry Executive Vice President, Operations | 472,333 | 394,013 | 0 | 0 | 10,000 | 876,346 |
| 2004-04-12 | 2002 | Mark L. Perry Executive Vice President, Operations | 411,329 | 365,505 | 0 | 0 | 10,000 | 786,834 |
| 2004-04-12 | 2001 | Mark L. Perry Executive Vice President, Operations | 375,417 | 298,125 | 0 | 0 | 10,000 | 683,542 |
| 2004-04-12 | 2003 | John F. Milligan Executive Vice President and Chief Financial Officer | 331,433 | 244,446 | 0 | 0 | 0 | 575,879 |
| 2004-04-12 | 2002 | John F. Milligan Executive Vice President and Chief Financial Officer | 274,933 | 163,548 | 0 | 0 | 0 | 438,481 |
| 2004-04-12 | 2001 | John F. Milligan Executive Vice President and Chief Financial Officer | 218,750 | 82,500 | 0 | 0 | 0 | 301,250 |
| 2004-04-12 | 2003 | Michael K. Inouye Senior Vice President, Commercial Operations | 329,550 | 181,716 | 0 | 0 | 10,000 | 521,266 |
| 2004-04-12 | 2002 | Michael K. Inouye Senior Vice President, Commercial Operations | 310,298 | 176,700 | 0 | 0 | 10,000 | 496,998 |
| 2004-04-12 | 2001 | Michael K. Inouye Senior Vice President, Commercial Operations | 284,864 | 154,508 | 0 | 0 | 10,000 | 449,372 |
| 2003-04-07 | 2002 | William A. Lee Senior Vice President, Research and Product Development | 282,259 | 145,788 | 0 | 0 | 0 | 428,047 |
| 2003-04-07 | 2002 | John C. Martin President and Chief Executive Officer | 653,334 | 616,000 | 0 | 0 | 0 | 1,269,334 |
| 2003-04-07 | 2001 | John C. Martin President and Chief Executive Officer | 548,340 | 500,000 | 0 | 0 | 0 | 1,048,340 |
| 2003-04-07 | 2000 | John C. Martin President and Chief Executive Officer | 478,125 | 56,250 | 0 | 0 | 0 | 534,375 |
| 2003-04-07 | 2002 | Norbert W. Bischofberger Executive Vice President, Research and Development | 429,750 | 315,000 | 0 | 0 | 0 | 744,750 |
| 2003-04-07 | 2001 | Norbert W. Bischofberger Executive Vice President, Research and Development | 375,417 | 250,000 | 0 | 0 | 0 | 625,417 |
| 2003-04-07 | 2000 | Norbert W. Bischofberger Executive Vice President, Research and Development | 333,333 | 31,250 | 0 | 0 | 0 | 364,583 |
| 2003-04-07 | 2002 | Mark L. Perry Executive Vice President, Operations | 411,329 | 298,125 | 0 | 0 | 0 | 709,454 |
| 2003-04-07 | 2001 | Mark L. Perry Executive Vice President, Operations | 375,417 | 250,000 | 0 | 0 | 0 | 625,417 |
| 2003-04-07 | 2000 | Mark L. Perry Executive Vice President, Operations | 318,506 | 31,250 | 0 | 0 | 0 | 349,756 |
| 2003-04-07 | 2002 | Michael K. Inouye Senior Vice President, Commercial Operations | 310,298 | 154,508 | 0 | 0 | 0 | 464,806 |
| 2003-04-07 | 2001 | Michael K. Inouye Senior Vice President, Commercial Operations | 284,864 | 96,000 | 0 | 0 | 0 | 380,864 |
| 2003-04-07 | 2000 | Michael K. Inouye Senior Vice President, Commercial Operations | 250,753 | 20,000 | 0 | 0 | 0 | 270,753 |
| 2003-04-07 | 2001 | William A. Lee Senior Vice President, Research and Product Development | 268,545 | 75,000 | 0 | 0 | 0 | 343,545 |
| 2003-04-07 | 2000 | William A. Lee Senior Vice President, Research and Product Development | 236,172 | 33,000 | 0 | 0 | 0 | 269,172 |
| 2002-04-10 | 1999 | Crispin G.S. Eley Senior Vice President, Pharmaceutical Operations | 224,008 | 63,600 | 0 | 0 | 0 | 287,608 |
| 2002-04-10 | 2000 | Crispin G.S. Eley Senior Vice President, Pharmaceutical Operations | 237,300 | 64,200 | 0 | 0 | 0 | 301,500 |
| 2002-04-10 | 2001 | Crispin G.S. Eley Senior Vice President, Pharmaceutical Operations | 260,415 | 115,052 | 0 | 0 | 0 | 375,467 |
| 2002-04-10 | 1999 | Nicole M. Onetto Senior Vice President, Medical Affairs | 268,800 | 75,000 | 0 | 0 | 0 | 343,800 |
| 2002-04-10 | 2000 | Nicole M. Onetto Senior Vice President, Medical Affairs | 283,478 | 77,228 | 0 | 0 | 0 | 360,706 |
| 2002-04-10 | 2001 | Nicole M. Onetto Senior Vice President, Medical Affairs | 327,700 | 286,900 | 0 | 0 | 0 | 614,600 |
| 2002-04-10 | 1999 | Mark L. Perry Executive Vice President, Operations | 275,514 | 140,000 | 0 | 0 | 0 | 415,514 |
| 2002-04-10 | 2000 | Mark L. Perry Executive Vice President, Operations | 318,506 | 31,250 | 0 | 0 | 0 | 349,756 |
| 2002-04-10 | 2001 | Mark L. Perry Executive Vice President, Operations | 375,417 | 250,000 | 0 | 0 | 0 | 625,417 |
| 2002-04-10 | 1999 | Norbert W. Bischofberger Executive Vice President, Research and Development | 247,075 | 140,000 | 0 | 0 | 0 | 387,075 |
| 2002-04-10 | 2000 | Norbert W. Bischofberger Executive Vice President, Research and Development | 333,333 | 31,250 | 0 | 0 | 150,000 | 514,583 |
| 2002-04-10 | 2001 | Norbert W. Bischofberger Executive Vice President, Research and Development | 375,417 | 250,000 | 0 | 0 | 150,000 | 775,417 |
| 2002-04-10 | 1999 | John C. Martin President and Chief Executive Officer | 387,681 | 250,000 | 0 | 0 | 0 | 637,681 |
| 2002-04-10 | 2000 | John C. Martin President and Chief Executive Officer | 478,125 | 56,250 | 0 | 0 | 0 | 534,375 |
| 2002-04-10 | 2001 | John C. Martin President and Chief Executive Officer | 548,340 | 500,000 | 0 | 0 | 0 | 1,048,340 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
